Physician profile
Tu Doan
NPI 1861557712
$3,157.63
in general payments reported to CMS, 2019-2025
20 companies · $712 in 2025
The $712 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.55 · 2020: $261 · 2021: $284 · 2022: $488 · 2023: $747 · 2024: $620 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Entertainment: $23.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,055.31 |
| Entertainment | $23.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $481.27 | 2020-2025 | Wavelight Refractive Suite, Hydrus Microstent, Clareon Panoptix Pro |
| Sight Sciences, INC. | $445.07 | 2020-2023 | Tearcare System |
| Bausch & Lomb Americas INC. | $353.24 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Dompe US, INC. | $293.24 | 2023-2025 | Oxervate |
| Abbvie INC. | $266.01 | 2022-2023 | Durysta |
| Oyster Point Pharma, INC. | $188.91 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $157.44 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $153.37 | 2020-2023 | Cequa |
| Biotissue Holdings INC. | $139.48 | 2019-2024 | |
| Glaukos Corporation | $129.10 | 2024 | Photrexa |
| Nova Eye, INC. | $125.00 | 2024 | |
| Mallinckrodt Hospital Products INC. | $123.21 | 2020-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.09 | 2020-2021 | |
| Allergan, INC. | $53.18 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $43.67 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $23.93 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $20.45 | 2022 | |
| Optovue, INC. | $19.23 | 2020 | |
| Thea Pharma INC. | $18.22 | 2023 | |
| Kala Pharmaceuticals, INC. | $15.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tu Doan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.